Clinical trials recruiting for Anal Cancer

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Study Regarding Tissue Response During and After Treatment for Anal Cancer
  NCT05939401 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer
  NCT04792892 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens
  NCT06327568 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Beyond Survival: Addressing Gynecological and Sexual Health in Women After Radiotherapy for Anal Cancer
  NCT07296237 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 3 locations
• DESTINY-PANTUMOUR04
  NCT07124000 · Phase: Not specified · Ages: 18 Years to 130 Years · Sex: All (male and female) · 36 locations
• Deciphering Mechanisms Underlying Cancer Immunogenicity
  NCT03958240 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Detecting HPV DNA in Anal and Cervical Cancers
  NCT04857528 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Distance-Based Exercise to Preserve Function and Prevent Disability
  NCT07059884 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 18 locations
• E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
  NCT05639972 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
  NCT05686226 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
  NCT06263088 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• HPV Genotype Attribution and Disease Burden of Anal Cancer in China
  NCT06670495 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• HRYZ-T101 Injection for HPV18 Positive Solid Tumor
  NCT05952947 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Host Genome Methylation: a Screening Tool in Anal Cancer Detection
  NCT06792604 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial
  NCT06522256 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Integrated Cancer Repository for Cancer Research
  NCT02012699 · Phase: Not specified · Ages: 19 Years to 110 Years · Sex: All (male and female) · 84 locations
• Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy
  NCT04094454 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)
  NCT07782164 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Multidimensional Examination of Patients with Colorectal and Anal Cancer
  NCT06562140 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 2 locations
• NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer
  NCT05572801 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 13 locations
• Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
  NCT06904365 · Phase: Not specified · Ages: 18 Years to 50 Years · Sex: Female · 2 locations
• Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG 5)
  NCT05055635 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA
  NCT06207981 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 114 locations
• SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
  NCT06544720 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis
  NCT07029152 · Phase: Not applicable (e.g. observational or device study) · Ages: 35 Years and older · Sex: Male · 16 locations
• Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.
  NCT03061435 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: Female · 1 location
• Self-sampling to Optimize Anal Lesion Outcomes
  NCT07192055 · Phase: Not applicable (e.g. observational or device study) · Ages: 35 Years and older · Sex: All (male and female) · 3 locations
• Stigma and Psychological profilE in REctal-anal caNcer pAtients
  NCT06366841 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
  NCT06493019 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
  NCT04907643 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: All (male and female) · 2 locations
• ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer
  NCT07425054 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Related conditions

Trials recruiting for Anal Cancer often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Anal Cancer trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.